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Abstract Computer-automated time-lapse analysis has been shown to improve embryo selection by providing quantitative and ob-
jective information to supplement traditional morphology. In this multi-centre study, the relationship between such computer-
derived outputs (High, Medium, Low scores), embryo implantation and clinical pregnancy were examined. Data were collected from
six clinics, including 205 patients whose embryos were imaged by the EevaTM System. The Eeva scores were blinded and not consid-
ered during embryo selection. Embryos with High and Medium scores had signiﬁcantly higher implantation rates than those with
Low scores (37% and 35% versus 15%; P < 0.0001; P = 0.0004). Similar trends in implantation rates were observed in different IVF
centres each using their own protocols. Further analysis revealed that patients with at least one High embryo transferred had sig-
niﬁcantly higher clinical pregnancy rates than those with only Low embryos transferred (51% versus 34%; P = 0.02), although pa-
tients’ clinical characteristics across groups were comparable. These data, together with previous research and clinical studies, conﬁrm
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that computer-automated Eeva scores provide valuable information, which may improve the clinical outcome of IVF procedures and
ultimately facilitate the trend of single embryo selection.
© 2014 Reproductive Healthcare Ltd. Published by Elsevier Ltd. All rights reserved.
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Introduction
Elective single-embryo transfer (SET) is increasingly pro-
moted in IVF clinical practice as an approach to help reduce
multiple births (Johnston et al., 2014), which have been as-
sociated with higher risk of adverse perinatal and maternal
outcomes (Gerris et al., 1999, 2002; van Montfoort et al., 2005;
Vilska et al., 1999), in addition to increased ﬁnancial cost
(Bromer et al., 2011; De Sutter et al., 2002). The challenge
of using elelctive SET in clinical practice, however, lies in en-
suring that the selection of a single embryo for transfer results
in the same pregnancy rates compared with double-embryo
transfer or multiple-embryo transfer. Currently, morphol-
ogy based embryo selection is the most widely used method
in clinical practice (Abeyta and Behr, 2014); however, snap-
shot morphological assessment alone has had limited success
owing to dynamic changes in embryo morphology over time
(Montag et al., 2011). To achieve high pregnancy rates while
reducing multiple embryo transfer, improved embryo selec-
tion methods are needed.
Time-lapse imaging is an emerging, non-invasive technol-
ogy that allows for the identiﬁcation of promising kinetic pa-
rameters that may improve the success rates of embryo
selection (Aparicio et al., 2013; Chen et al., 2013; Kirkegaard
et al., 2012;Wong et al., 2013). Recently, a number of embryo
selectionmethods based on time-lapse imaging have been re-
ported. Meseguer et al. (2011) used known implantation data
from day 3 embryo transfers, and developed a hierarchical
multivariable embryo selection method that categorizes
embryos into 10 grades using morphology and three timing
parameters: t5 (time to 5-cell), s2 (synchrony in divisions from
two-cell to four-cell) and cc2 (duration of second cell cycle).
Later, the same group applied this model retrospectively to
examine patient pregnancy as an end-point, and found that
the classiﬁcation results correlated to pregnancy rates
(Mesegueret al., 2012).More recently, embryo selectionmodels
have been developed using aneuploidy data obtained after
blastomere or trophectoderm biopsy. Campbell et al. (2013a)
developed an aneuploidy risk classiﬁcation model for blas-
tocyst stage embryos based on the start time of blastulation
and time to the fully expanded blastocyst stage. The same
group later evaluated the model against blastocyst implan-
tation in a retrospective study, and found the classiﬁcation
results correlated to probability of implantation (Campbell
et al., 2013b). Basile et al. (2014) published an embryo se-
lection method, also based on embryo developmental kinet-
ics, which ranks the probability of day 3 embryos being
chromosomally normal. These studies are valuable towards
evaluating embryo selection models in appropriately de-
signed randomized controlled trials. To the best of our knowl-
edge, however, themethods abovehavenot yet been validated
using prospective independent clinical data and the equiva-
lent end-points that the models were developed upon.
Recently, Conaghan et al. (2013) published an embryo clas-
siﬁcation model that, when used adjunctively with tradi-
tional morphology, can predict embryo development potential
at the cleavage stage (the EevaTM Test). The classiﬁcation
model was based on two cell division timing parameters, P2
(time between the ﬁrst and second mitosis, or duration of the
2-cell stage) and P3 (time between the second and third
mitosis, or duration of the three-cell stage), both of which
have been shown in different studies to consistently corre-
late to embryo development, implantation potential, or both
(Chavez et al., 2012; Cruz et al., 2012; Hlinka et al., 2012;
Meseguer et al., 2011; Rubio et al., 2012; Wong et al., 2010).
Importantly, P2 and P3 could be automatically extracted from
time-lapse video recordings by state-of-the-art computer vision
software that helps reduce the need for manual video anno-
tation (Conaghan et al., 2013). Conaghan et al. (2013) vali-
dated the performance of the model in several unique ways.
First, an independent dataset was used to validate the model
performance. Second, the dataset was probed for the same
end-point that the model was originally established upon.
Finally, the model was tested adjunctively with traditional
morphology and shown to signiﬁcantly improve a group of em-
bryologists’ abilities to identify embryos with higher devel-
opmental potential. To further assess the clinical value of the
model, the aim of this study was to examine if computer-
automated prediction scores for embryo development po-
tential also correlate to embryo implantation, patient
pregnancy, or both.
Materials and methods
Data included in this retrospective study were collected from
six IVF clinics in the USA. Institutional Review Board ap-
proval was obtained at each site (IRB reference number and
date of approval for each site: University of Pennsylvania:
number 817180, 16 January 2013; Paciﬁc Fertility Center:
number 1122828, 29 December 2011; HRC Fertility: number
1128064, 27 September 2011; Reproductive Science Centre:
number 1122464, 22 December 2011; Fertility Physicians of
Northern California: number 1122761, 29 December 2011;
Stanford University: number 20335, 11 January 2011). Pa-
tients undergoing assisted reproduction treatment between
June 2011 and December 2013 were approached and con-
sented to have their embryos imaged. Patients underwent
ovarian stimulation according to guidelines of each clinic,
where protocols included agonist luteal phase, agonist
microdose ﬂare and antagonist suppression. On the day of
oocyte retrieval (day 0), oocytes were fertilized using con-
ventional insemination protocols or by intracytoplasmic sperm
injection. Immediately after fertilization assessment, nor-
mally fertilized oocytes (2PNs) were placed into a multiwell
Eeva Dish. The microwell format of the petri-dish holds
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individual embryos separately but in close proximity under
a shared media droplet, whereas reference labels provide
visual orientation of each embryo’s speciﬁc location within
the dish array. Throughout embryo culture, each clinical site
used its own laboratory protocols, including their standard
culture media, protein supplementation, media exchange pro-
tocol (if necessary) and incubation environment.
Embryos were imaged using the Eeva System (Auxogyn, Inc.,
Menlo Park, CA, USA), a time-lapse enabled system that gen-
erates automated prediction scores to predict embryo de-
velopment in adjunct with traditional morphology. Brieﬂy, the
Eeva System includes microscopes that ﬁt into a standard in-
cubator and use dark ﬁeld imaging to capture high resolu-
tion, single-plane images of embryos housed in a multi-well
Eeva Dish, in 5-min intervals. To maintain a continuous and
uninterrupted imaging process from day 1 to day 3, no media
changes or excursions from the incubator were permitted after
day 1 and before day 3. Embryo morphology assessment on
different culture days, embryo grading, selection and trans-
fer were carried out according to the standard operating
procedures of each individual clinic. As this was a blinded non-
selection study, embryos that were selected for transfer or
for freezing were based on traditional morphology grading only
according to each clinic’s protocol. Clinical pregnancy and suc-
cessful implantation were conﬁrmed by ultrasound showing
evidence of intrauterine fetal heart beat at about 6–8 weeks’
gestational age. Implantation rate was deﬁned as the number
of gestational sacs with fetal heart beat divided by the number
of embryos transferred. Clinical pregnancy rate was deﬁned
as the number of patients who had visible fetal heartbeat
at 6–8 weeks’ gestational age divided by the total number of
patients.
Image data were analysed by the Eeva System’s com-
puter vision software, which automatically extracts P2 and
P3 timings for each embryo, feeds the timings into an estab-
lished statistical classiﬁcation model, and generates a pre-
dictive score of whether the embryo has a ‘High’ or ‘Low’
probability of developing to a usable blastocyst (Conaghan
et al., 2013). In this retrospective analysis, two different ver-
sions of the Eeva outputs were studied: the original two-
category output, which gives an Eeva High (P2: 9.33 ≤ P2 ≤
11.45 h; P3: 0 ≤ P3 ≤ 1.73 h) or Eeva Low (P2, P3, or both,
out of the Eeva High window) score (Conaghan et al., 2013);
and a new, further sub-divided, three-category output which
gives an Eeva High (9.33 ≤ P2 ≤ 11.45 h; 0 ≤ P3 ≤ 1.73 h), Eeva
Medium (not Eeva High: 9.33 ≤ P2 ≤ 12.65 h; P3: 0 ≤ P3 ≤ 4 h)
or Eeva Low (P2, P3, or both, out of the Eeva High and Eeva
Medium window) score. Rates of implantation and clinical
pregnancy could be calculated for all single embryo trans-
fers and, in cases of multiple embryo transfers, when all trans-
ferred embryos were of the same Eeva score.
Statistical data analysis was carried outu using SAS 9.3 (SAS
Institute Inc., North Carolina, USA). Student’s t-test, chi-
squared test, Fisher’s exact or one-way analysis of variance
was used to calculate P-values. A comparison with P < 0.05
was considered to have statistically signiﬁcant difference.
Results
This retrospective analysis included 205 patients whose
transferred embryos had P2 and P3 timings automatically
extracted by the computer programme, to investigate a pos-
sible association between the Eeva scores and rates of embryo
implantation and clinical pregnancy. The patient clinical char-
acteristics are described in Table 1. From these 205 pa-
tients, a total of 375 embryos were transferred, resulting in
an overall 29% (110/375) implantation rate and 45% (93/
205) clinical pregnancy rate. Of the embryos that were trans-
ferred, 331 embryos had implantation status conﬁrmed;
implantation status of 44 embryos could not be determined
owing to transfer of multiple embryos with different Eeva
scores; therefore, they were excluded from data analysis.
Two-category (High/Low) output and rates of
embryo implantation and clinical pregnancy
To examine the association between the Eeva two-category
output (High/Low) and embryo implantation, we analysed the
implantation rates for transferred embryos with known im-
plantation (n = 331 embryos). The overall known implanta-
tion rate for this dataset was 27% (91/331) and was calculated
using only those patients for whom implantations could be
matched with speciﬁc embryo(s) transferred. Known implan-
tation rate is typically lower than implantation rates that are
calculated when all patients are included (Rubio et al., 2012),
because some of the cases with partial implantation are ex-
cluded and therefore non-implanted embryos are over-
represented. We found that High embryos had a higher
probability of successful implantation (37%, 41/111) than Low
embryos (23%, 50/220) (Figure 1), and the difference in im-
plantation rates was statistically signiﬁcant (P = 0.003).
To examine the association between the Eeva two-category
output (High and Low) and clinical pregnancy rates, 205 pa-
tients were divided into two groups: patients with at least one
High embryo transferred and those with no High embryo trans-
ferred. The patients’ clinical characteristics for the two groups
were compared, including egg age, number of eggs re-
trieved, number of 2PNs on day 1 and number of embryos
transferred. No statistically signiﬁcant difference were found
for any of the clinical characteristics assessed (Table 2). Pa-
tients with at least one High embryo, transferred, however,
had statistically signiﬁcantly higher clinical pregnancy rates
than those with no High embryos transferred (51% versus 39%;
P = 0.04) (Table 2).
Three-category (High, Medium and Low)
output and rates of embryo implantation and
clinical pregnancy
As 50 out of 205 patients (24%) only had Low embryos avail-
able, we hypothesized that having a three-category Eeva
output that further separated the Low category into a Medium
and a Low subcategory may help embryo selection for these
patients. With the three-category output, 155 out of 205 (76%)
patients had High embryos, 31 out of 205 patients (15%) had
no High but had Medium, Low embryos, or both, and 19 out
of 205 of patients (9%) had only Low embryos available. Indeed,
after introducing the Medium category, the frequency of pa-
tients who had only Low embryos dropped from 24% to 9%.
We next examined if the three-category output (High,
Medium and Low) relates to embryo implantation. High
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embryos had the highest likelihood of implantation (37%, 41/
111), followed by Medium (35%, 29/83), and Low (15%, 21/
137) (Figure 2). The difference in implantation rates between
high compared with low embryos and medium compared with
low embryos was statistically signiﬁcant (P < 0.0001;
P = 0.0004, respectively), suggesting that implantation rates
are also associated with an Eeva three-category output.
To analyse the relationship between the three-category
output and clinical pregnancy rates, patients were divided into
three groups: at least one High embryo transferred; no High
but at least one Medium transferred; no High or Medium trans-
ferred. Similar to the two-category breakdown, the pa-
tients’ clinical characteristics across three groups, measured
by egg age, number of eggs, number of embryos and number
of embryos transferred, were statistically equivalent (tested
by one-way analysis of variance). Patients with one or more
High embryos transferred, however, had statistically signiﬁ-
cantly higher clinical pregnancy rates than those with no High
or Medium embryos transferred (51% versys 34%; P = 0.02)
(Table 3). These results show that the difference in clinical
pregnancy rates between High and Low patient groups can
be augmented when a Medium category is introduced.
Eeva scores and embryo implantation
in different clinics
Finally, the association between Eeva scores and embryo im-
plantation in the three clinics that contributed most of the
data (deﬁned by having at least 50 or more transferred
embryos with known implantation) were analysed. The three
clinics followed their own standard procedure for embryo
culture and embryo selection for transfer, where variations
included IVF versus intracytoplasmic sperm injection, oxygen
concentration at 5% versus 20%, VitroLife versus Sage versus
Irvine Scientiﬁc culture media, and sequential versus single-
step media culture protocols. Different overall known im-
plantation rates were observed for each site (site A: 25%; site
B: 32%; site C: 23%). The relationship between Eeva scores
and implantation, however, was observed across all three sites:
High embryos consistently had better implantation rates than
Table 1 Clinical characteristics for patients included in this study.
Total number of patients 205
Total number of eggs 3523
Total number of 2PNs 2142
Egg age (years) (mean ± SD) 33.1 ± 5.1
Recipient age (years) (mean ± SD) 35.7 ± 5.2
Cycle type Patient using own eggs n (%) 176/205 (86)
Oocyte donor n (%) 29/205 (14)
Reason for assisted
reproductive technology
Male infertility n (%) 39/205 (19)
History of endometriosis n (%) 5/205 (2)
Ovulation disorders n (%) 14/205 (7)
Diminished ovarian reserve n
(%)
33/205 (16)
Tubal factor n (%) 5/205 (2)
Uterine n (%) 2/205 (1)
Unexplained/other n (%) 53/205 (26)
Multiple reasons n (%) 54/205 (26)
Stimulation protocol Agonist luteal phase n (%) 55/205 (27)
Agonist micro-dose ﬂare n (%) 11/205 (5)
Antagonist suppression n (%) 102/205 (50)
Other n (%) 37/205 (18)
Egg retrieval count Number of eggs (mean ± SD) 17.4 ± 8.5
Method of insemination Intracytoplasmic sperm
injection n (%)
119/205 (58)
IVF n (%) 76/205 (37)
Both n (%) 3/205 (1)
Unknown n (%) 7/205 (3)
Fertilization count (mean ± SD) Number of 2PNs (mean ± SD) 10.6 ± 5.5
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Figure 1 Implantation rates for Eeva two-category High versus
Low scored embryos. Error bars represent 95% upper conﬁ-
dence limit. The difference in implantation rates between Eeva
High versus Eeva Low embryos is statistically signiﬁcant: P = 0.003.
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Low embryos, and the difference in implantation rates
between these two categories was statistically signiﬁcant for
all three sites (sites A and B: P = 0.02; site C: P = 0.002)
(Figure 3).
Discussion
In this blinded multi-centre study, our results indicate that
computer-automated time-lapse analyses data are related to
embryo implantation and clinical pregnancy. The three-
category output by computer automated analyses further set
apart the difference in implantation rates between High and
Low scored embryos. Furthermore, the association between
the computer-generated predictive scores and embryo im-
plantation was observed for different IVF centres using their
own embryo culture protocols.
Timing parameters, P2 and P3, have been shown in dif-
ferent studies to consistently correlate to embryo develop-
ment, implantation potential, or both (Chen et al., 2013).
Previously, it was demonstrated that the Eeva two-category
scores based on P2 and P3 timings could automatically predict
an embryo’s potential to develop into a usable blastocyst
(Conaghan et al., 2013). In the present study, this auto-
mated prediction model is also shown to relate to embryo
implantation and clinical pregnancy. Meseguer et al. (2011)
previously developed a time-lapse based embryo classiﬁca-
tion model, using implantation as an end-point, which
similarly included P2 and P3, although both timings re-
quired manual recording and input by human observers. The
parameters P2 and P3 have since been evaluated in mul-
tiple studies from various clinics. Most of these studies have
conﬁrmed statistically signiﬁcant correlations betweenmanual
assessment of P2, P3, or both, and embryo developmental
potential, implantation, or both (Chavez et al., 2012; Cruz
et al., 2012; Dal Canto et al., 2012; Hlinka et al., 2012;
Kirkegaard et al., 2013b; Meseguer et al., 2011; Rubio et al.,
2012; Wong et al., 2010). Two studies did not ﬁnd correla-
tions between P2, P3 and embryo quality (Campbell et al.,
2013a; Chamayou et al., 2013); however, both of these studies
evaluated P2 and P3 for a small subset of embryos (e.g. trans-
ferred blastocysts or biopsied blastocysts), instead of a
broader, more generalizable embryo population. In addi-
tion to blastocyst development and embryo implantation, other
developmental biological research investigating P2 and P3
have found these timings to be reﬂective of euploidy at the
cleavage-stage (Chavez et al., 2012) and gene expression
(Wong et al., 2010). Despite all possible variations in pub-
lished studies, P2 and P3 still stand out as two parameters
that are repeatedly reported by independent clinics and
various studies to be indicative of embryo viability, com-
pared with other parameters published (Kaser and Racowsky,
2014). As reproducibility is one of the main tenets of the
scientiﬁc method, our results, together with previous and
emerging published literature, demonstrate the predictive
value of early time-lapse parameters such as P2 and P3 in
differentiating embryos with higher developmental poten-
tial during embryo selection.
Two types of Eeva scores were analysed (i.e. two-
category High and Low, and three-category High, Medium
and Low). Both types of results were related to rates of embryo
implantation and clinical pregnancy. The introduction of
the Medium category may improve clinical utility by further
discriminating the embryos that fall into the two-category
low group. At the patient level, adding Medium reduced the
percentage of patients with only Low embryos to transfer
from 24% to 9%. At the embryo level, separating medium
embryos from the two-category low group helped further dif-
ferentiate the implantation potential within the Low embryos,
which comprised 66% of all transferred embryos in this blinded
study. In short, with the addition of a Medium category to
the model, embryos chosen for transfer could be further dif-
ferentiated by their implantation potential. ‘Low’ potential
embryos were not expected to have ‘no potential’ as a result
of adding a medium category to the model. Our results showed
that embryos with High, Medium or Low Eeva scores re-
sulted in relatively higher, medium and lower implantation
and pregnancy rates, and support the conclusion that the
Table 2 Clinical pregnancy rates and clinical characteristics for patients whose embryos were assessed by the Eeva System and had
at least one Eeva High embryo transferred or no Eeva High embryos transferred.
Patient group
Numbr of
patients
Egg age Numbr of
eggs retrieved
Number
of 2PN
Number of
embryos
transferred
Pregnancy
rate
At least one Eeva High transferred 105 33.0 ± 4.9 17.7 ± 8.4 11.0 ± 5.5 1.8 ± 0.8 51% (54/105)
No Eeva High embryos transferred 100 33.2 ± 5.3 17.0 ± 8.7 10.1 ± 5.5 1.8 ± 0.7 39% (39/100)a
aP = 0.04.
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Figure 2 Implantation rates for Eeva three-category High,
Medium and Low scored embryos. Error bars represent 95% upper
conﬁdence limit. Implantation rates between High versus Low and
Medium versus Low were signiﬁcantly different (P < 0.0001 and
P = 0.0004, respectively).
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Eeva information may be added to morphology to increase
the chance of selecting the embryo with higher viability. As
the use of time-lapse in the clinical setting increases and
more imaging data become available, advanced data mining
methods could be used to expand upon the current model,
and future models could be developed with more categories
to allow further reﬁned differentiation among embryos non-
invasively. Ultimately, a model that ranks embryos robustly
for individual patients may aid in further adoption of elec-
tive SET while minimizing patients’ time-to-pregnancy.
In this study, composed of data from multiple clinics,
computer-derived prediction results were strongly related to
embryo implantation in different IVF centres, each using their
own laboratory protocols, culture media, incubation envi-
ronment and insemination technique. Overall, and at indi-
vidual clinics, Eeva High, Medium and Low scores resulted in
relatively higher, medium and lower implantation and clini-
cal pregnancy rates. Our results suggest that a generaliz-
able model for optimal timing of embryo development may
be feasible. Three key elements may contribute to the general
applicability of the model we tested. First, the prediction
model was developed using data collected from a multi-
centre study (Conaghan et al., 2013) so that variability in cul-
turing conditions was incorporated during model development.
Second, the model has been validated for blastocyst predic-
tion using an independent dataset and the same end-points
as those the model was developed upon (Conaghan et al.,
2013). Third, a wide variety of researchers have reported that
P2 and P3 timings are negligibly inﬂuenced by a variety of ex-
ternal factors, including culture media (Basile et al., 2013),
oxygen concentration (Kirkegaard et al., 2013a), stimula-
tion protocols (Munoz et al., 2012) and insemination method
(Dal Canto et al., 2012). Interestingly, although the present
study was under review, a retrospective multi-centre analy-
sis published in a commentary examined whether the blas-
tocyst prediction model published by Conaghan et al.
correlates to implantation for seven independent clinics
(Kirkegaard et al., 2014). The investigators reported that
embryos that were manually analysed and classiﬁed as High
have a statistically signiﬁcantly higher implantation rate (30%
relative increase) than embryos that were manually analysed
and classiﬁed as Low (Kirkegaard et al., 2014). The ﬁnding from
Table 3 Clinical pregnancy rates and clinical characteristics for patients whose embryos were assessed by the Eeva System and had
at least one Eeva High embryo transferred; at least one Eeva Medium embryo transferred; or no Eeva High/Medium transferred.
Patient group
Number of
patients
Egg age Number of eggs
retrieved
Number
of 2PN
Number of embryos
transferred
Pregnancy
rate
At least one Eeva High
transferred
105 33.0 ± 4.9 17.7 ± 8.4 11.0 ± 5.5 1.8 ± 0.8 51% (54/105)a
No Eeva High and at least
one Eeva Medium
transferred
53 33.4 ± 5.3 16.0 ± 7.4 10.5 ± 5.0 1.8 ± 0.7 43% (23/53)
No Eeva High or Medium
transferred
47 32.9 ± 5.3 18.2 ± 10 9.6 ± 6.2 1.8 ± 0.7 34% (16/47)a
aFor ‘at least one Eeva High transferred’ versus ‘no Eeva High or Medium transferred’; P = 0.02.
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Figure 3 Implantation rates for embryos with Eeva High, Medium and Low scores from three clinical sites with at least 50 embryos
of known implantation data per site. Error bars represent 95% upper conﬁdence limit. For all three sites, the difference in implan-
tation rates between Eeva High versus Low embryos is statistically signiﬁcant (chi-squared test): P = 0.02 (site A); P = 0.02 (site B);
P = 0.002 (site C).
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Kirkegaard et al. (2014) is consistent with our conclusion that
a predictive model based on P2 and P3 relates to higher com-
pared with lower implantation, and may therefore aid in
embryo assessment. As far as is known, the present study was
the ﬁrst evaluation of implantation for a computer-automated
test that does not require manual analysis of these critical
parameters. Furthermore, results are introduced for a novel
Medium group, a secondary analysis of clinical pregnancy
at the patient level, and evaluation of the performance of
the model at individual clinics. Our work and the work of
others, therefore, support the idea of a generalizable embryo
assessment model. Speciﬁcally, our study uses time-lapse and
clinical data from multiple IVF centres undergoing their own
standard procedures for stimulation, egg retrieval, embryo
culture and insemination, suggests broad applicability for a
computer-automated, P2-, P3-based predictive model in
diverse clinical IVF laboratories.
As this study was blinded and time-lapse scores were not
considered during embryo selection, all the cases were
analysed retrospectively to estimate the percentage of pa-
tients who could potentially have had a different embryo
selected if time-lapse scores were available. For the two-
category Eeva output, 100 patients had no High embryos se-
lected for transfer. Thirty-three of these patients (33%,
33/100) had at least one High embryo that was not trans-
ferred, but exhibited equivalent morphology to the embryo(s)
that were selected for transfer. Notably, our patient popu-
lation included those who had many candidate embryos for
transfer, and were therefore in particular need of embryo se-
lection assistance. For these patients, the availability of ad-
ditional high embryo(s) suggests that, with the assistance of
an automated time-lapse model, alternative embryos with
higher implantation potential could have been selected for
transfer. Therefore, using time-lapse results during embryo
selection could potentially beneﬁt a signiﬁcant number of pa-
tients; however, the speciﬁc degree of improvement in re-
productive outcome must be assessed in a well-designed
randomized controlled trial, the gold standard to evaluate the
effectiveness and clinical implementation of any new tech-
nology. The present retrospective patient case analysis pro-
vides key information valuable for the design of a meaningful
randomised controlled trial.
This study has demonstrated that prediction models based
on computer-extracted P2 and P3 timings show a strong re-
lationship with embryo implantation and clinical preg-
nancy. Recent research studies have focused on the
identiﬁcation of additional timing parameters that corre-
late to embryo development, chromosomal normality, embryo
implantation, or both (including those that span the ﬁrst cell
cycle, the cleavage stage, morula to blastocyst stage, or both)
(Aguilar et al., 2014; Athayde Wirka et al., 2014; Basile et al.,
2014; Campbell et al., 2013a). These new parameters, if ro-
bustly demonstrated to be predictive of embryo viability, may
be combined with currently validated timings to further
improve embryo selection. Increasingly, time-lapse
research is appropriately focused on testing the value of
embryo developmental timing parameters and selection
models in prospective randomized studies (Aparicio et al.,
2013). These studies promise to reset the standard of embryo
selection in IVF clinical practice and move the ﬁeld of as-
sisted reproductive technology towards ‘one healthy baby at
a time’.
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